Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
    5.
    发明公开
    Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis 失效
    Leishmanien-Antigene zur Verwendung bei der Therapie und Diagnus von Leishmaniose

    公开(公告)号:EP2284186A1

    公开(公告)日:2011-02-16

    申请号:EP10177490.9

    申请日:1998-02-12

    摘要: Compositions and methods for preventing, treating and detecting leishmaniasis and stimulating immune responses in patients are disclosed. The compounds provided include polypeptides that contain at least an immunogenic portion of one or more Leishmania antigens, or a variant thereof. Vaccines and pharmaceutical compositions comprising such polypeptides, or DNA molecules encoding such polypeptides, are also provided and may be used, for example, for the prevention and therapy of leishmaniasis, as well as for the detection of Leishmania infection.

    摘要翻译: 公开了预防,治疗和检测利什曼病并刺激患者免疫应答的组合物和方法。 提供的化合物包括含有至少一种或多种利什曼原虫抗原的免疫原性部分或其变体的多肽。 还提供了包含这种多肽的疫苗和药物组合物,或编码这些多肽的DNA分子,并且可以用于例如预防和治疗利什曼病以及利什曼原虫感染的检测。

    Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
    7.
    发明公开
    Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use 失效
    化合物用于免疫治疗和诊断结核病,和使用它们的方法

    公开(公告)号:EP2172551A2

    公开(公告)日:2010-04-07

    申请号:EP08172265.4

    申请日:1998-05-20

    IPC分类号: C12N15/31 C07K14/35 A61K39/04

    摘要: Compounds and methods for inducing protective immunity against tuberculosis are disclosed. The compounds provided include polypeptides that contain at least one immunogenic portion of one or more M. Tuberculosis proteins and DNA molecules encoding such polypeptides. Such compounds may be formulated into vaccines and/or pharmaceutical compositions for immunization against M. Tuberculosis infection, or may be used for the diagnosis of tuberculosis.

    摘要翻译: 抗结核诱导保护性免疫化合物和方法可以游离缺失盘。 所提供的化合物包括多肽也含有一种或多种结核分枝杆菌蛋白和编码检测所述多肽的DNA分子中的至少一个免疫原性部分。 搜索化合物可以配制成疫苗和/或药物组合物用于对结核分枝杆菌感染免疫,或可用于结核病的诊断。